VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
S-1MEF

Registration of up to an additional 20% of securities for any offering registered on an S-1

Registration Statements
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
EFFECT

EFFECT

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |